Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for NK1 1
Most Correlated Studies
- Thymic invariant natural killer T cells (CD24- CD44+/- NK1.1-) with Id3 knockout
- Gr-1+ monocytes derived from spleen and blood
- Natural killer and natural killer T cells from Eomes reporter mice
- Thymocytes double negative 3 (DN3) conditionally overexpressing miR-185
- Dendritic cell populations CCL17-positive (lymph nodes) or CCL17-negative (spleen)
Most Relevant Literature
- Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3…
- LLT1-CD161 Interaction in Cancer: Promises and Challenges.
- Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic ca…
- Targeting of the CD161 inhibitory receptor enhances T-cell-mediated immunity against hematological m…
- Immune checkpoint CD161/LLT1-associated immunological landscape and diagnostic value in oral squamou…
Most Relevant Clinical Trials
- A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prur…
- HBPL Study of the Impact of the NK1 Antagonist Aprepitant
- Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With […
- A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bull…
- Neurokinin (NK) 1 Antagonist for Pathological Aggression for Harmful, Impulsive, and Self-/Aggressiv…
